Using SMART Experimental Design to Personalize Treatment for Child Depression

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Depression
Interventions
BEHAVIORAL

Cognitive Behavioral Therapy (CBT)

Children will first be randomized into Stage 1 of CBT or Caregiver-Child Treatment. Stage 1 will include six sessions. After Stage 1, child's response to treatment will be evaluated. Responders will be re-randomized into Stage 2 of no treatment or continuation of CBT. If randomized to no treatment, termination session will be completed. If randomized to continuation of CBT, the treatment will include six sessions and a termination session. Insufficient responders will be re-randomized into Stage 2 of continuation of CBT or Caregiver-Child Treatment. Stage 2 will include six sessions and a termination session.

BEHAVIORAL

Caregiver-Child Treatment

Children will first be randomized into Stage 1 of CBT or Caregiver-Child Treatment. Stage 1 will include six sessions. After Stage 1, child's response to treatment will be evaluated. Responders will be re-randomized into Stage 2 of no treatment or continuation of Caregiver-Child Treatment. If randomized to no treatment, termination session will be completed. If randomized to continuation of Caregiver-Child Treatment, the treatment will include six sessions and a termination session. Insufficient responders will be re-randomized into Stage 2 of continuation of Caregiver-Child Treatment or CBT. Stage 2 will include six sessions and a termination session.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT01880814 - Using SMART Experimental Design to Personalize Treatment for Child Depression | Biotech Hunter | Biotech Hunter